1
|
Salem AH, Agarwal SK, Dunbar M, Enschede SLH, Humerickhouse RA, Wong SL. Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma. J Clin Pharmacol 2016; 57:484-492. [DOI: 10.1002/jcph.821] [Citation(s) in RCA: 69] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 08/19/2016] [Indexed: 11/09/2022]
Affiliation(s)
- Ahmed Hamed Salem
- Clinical Pharmacology and Pharmacometrics; AbbVie Inc; North Chicago IL, USA
- Clinical Pharmacy; Faculty of Pharmacy; Ain Shams University; Cairo Egypt
| | - Suresh K. Agarwal
- Clinical Pharmacology and Pharmacometrics; AbbVie Inc; North Chicago IL, USA
| | - Martin Dunbar
- Clinical Pharmacology and Pharmacometrics; AbbVie Inc; North Chicago IL, USA
| | | | | | - Shekman L. Wong
- Clinical Pharmacology and Pharmacometrics; AbbVie Inc; North Chicago IL, USA
| |
Collapse
|